ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells()

Breast cancer treatment often includes Doxorubicin as adjuvant as well as neoadjuvant chemotherapy. Despite its cytotoxicity, cells can develop drug resistance to Doxorubicin. Uncovering pathways and mechanisms involved in drug resistance is an urgent and critical aim for breast cancer research orie...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessandrini, Federica, Pezzè, Laura, Menendez, Daniel, Resnick, Michael A., Ciribilli, Yari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077117/
https://www.ncbi.nlm.nih.gov/pubmed/30025229
http://dx.doi.org/10.1016/j.neo.2018.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077117/
https://www.ncbi.nlm.nih.gov/pubmed/30025229
http://dx.doi.org/10.1016/j.neo.2018.06.008

Ejemplares similares